Look behind the lecture with Dalia Dawoud: network meta-analyses and indirect treatment comparisons in HTA

27 Aug 2021

Written by DALIA DAWOUD (NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE)

Health technology assessment ISPOR Look behind the lecture Methodology

In this feature, following participating in a Workshop at the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR; NJ, USA) 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Dalia Dawoud, Senior Scientific Adviser at the National Institute for Health and Care Excellence (NICE; London, UK), discusses the current landscape of use of network meta-analyses (NMAs) and indirect treatment comparisons (ITCs) in health technology assessment (HTA) submissions, and more! Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? I am Dalia Dawoud, Senior Scientific Adviser at NICE. I am part of a...